Hepcidin expression levels involve efficacy of pegylated interferon-α treatment in hepatitis B-infected liver.
Sign Up to like & getrecommendations! Published in 2022 at "International immunopharmacology"
DOI: 10.1016/j.intimp.2022.108641
Abstract: BACKGROUND Hepcidin is the master iron regulator hormone produced by the liver. The association of serum hepcidin with pegylated interferon therapy in patients with chronic hepatitis C infection has been studied. However, the role of… read more here.
Keywords: expression; pegylated interferon; hepcidin; treatment ... See more keywords
Pegylated interferon alpha - 2a is clinically effective and tolerable in myeloproliferative neoplasm patients treated off clinical trial.
Sign Up to like & getrecommendations! Published in 2017 at "Leukemia research"
DOI: 10.1016/j.leukres.2017.01.006
Abstract: Polycythemia vera, essential thrombocytosis, and myelofibrosis are chronic Philadelphia-negative myeloproliferative neoplasms that are characterized by clonal hematopoiesis, splenomegaly, risk of hemorrhagic and thrombotic sequelae, and profound symptom burden. We review the outcomes of 75 myeloproliferative… read more here.
Keywords: pegylated interferon; clinical trial; interferon alpha;
Efficacy and Safety of Interferon Alpha 2A and Pegylated Interferon Alpha 2A in Inflammatory Macular Edema
Sign Up to like & getrecommendations! Published in 2019 at "Ocular Immunology and Inflammation"
DOI: 10.1080/09273948.2019.1604001
Abstract: ABSTRACT Purpose: The aim of this study was to further explore the efficacy and safety of interferon-α in refractory non-infectious inflammatory macular edema and to compare interferon-α2a and pegylated interferon-α2b. Methods: 34 patients with refractory… read more here.
Keywords: interferon alpha; pegylated interferon; efficacy safety; interferon ... See more keywords
Effectiveness of Pegylated Interferon Alpha-2a in Post-Uveitic Macular Edema Previously Responding to Non-Pegylated Interferon.
Sign Up to like & getrecommendations! Published in 2023 at "Ocular immunology and inflammation"
DOI: 10.1080/09273948.2023.2195494
Abstract: PURPOSE To evaluate the efficacy of pegylated interferon (PEG-IFN) alpha-2a to treat post-uveitic relapsing macular edema (ME) after withdrawal of non-PEG IFN alpha-2a or 2b to maintain treatment efficacy. METHODS This retrospective study investigated subjects… read more here.
Keywords: peg ifn; pegylated interferon; alpha; interferon ... See more keywords
Pegylated Interferon Alpha 2a for the Treatment of Ocular Surface Squamous Neoplasia
Sign Up to like & getrecommendations! Published in 2022 at "Cornea"
DOI: 10.1097/ico.0000000000003086
Abstract: Purpose: The purpose of this study was to introduce the initial experience in the use of topical pegylated interferon alpha 2a (PegIFN-α-2a) for ocular surface squamous neoplasia (OSSN). Methods: A retrospective medical record review of… read more here.
Keywords: surface squamous; squamous neoplasia; interferon alpha; pegylated interferon ... See more keywords
Efficacy and safety of telaprevir with pegylated interferon α‐2a and ribavirin in Japanese patients
Sign Up to like & getrecommendations! Published in 2017 at "Hepatology Research"
DOI: 10.1111/hepr.12722
Abstract: To assess the efficacy and safety of telaprevir (TVR) in combination with pegylated interferon α‐2a (PEG‐IFNα‐2a) and ribavirin (RBV) for treatment‐naïve patients and relapsed patients compared to previous TVR‐based triple therapy in Japan. read more here.
Keywords: efficacy safety; telaprevir pegylated; pegylated interferon; safety telaprevir ... See more keywords
Higher efficacy of pegylated interferon‐α2b add‐on therapy in hepatitis B envelope antigen‐positive chronic hepatitis B patients on tenofovir monotherapy
Sign Up to like & getrecommendations! Published in 2018 at "Hepatology Research"
DOI: 10.1111/hepr.13049
Abstract: Monotherapy with pegylated interferon‐α (Peg‐IFNα) or the nucleos(t)ide analogs (NA) currently approved for treating chronic hepatitis B (CHB) has limited efficacy. Studies on the combination of Peg‐IFNα/NA have shown conflicting results. We investigated whether sequentially… read more here.
Keywords: chronic hepatitis; hepatitis; pegylated interferon; efficacy ... See more keywords
Kinetics changes in total cholesterol predict HBeAg seroconversion in chronic hepatitis B patients treated with pegylated interferon‐alfa
Sign Up to like & getrecommendations! Published in 2022 at "Journal of Viral Hepatitis"
DOI: 10.1111/jvh.13787
Abstract: There is no satisfactory standard for predicting HBeAg seroconversion during Pegylated interferon alpha (PegIFNα) treatment. Studies have shown that IFNα therapy in chronic hepatitis C patients could alter serum lipid profiles. However, there have been… read more here.
Keywords: chronic hepatitis; pegylated interferon; hbeag seroconversion; seroconversion ... See more keywords
Pegylated Interferon in Myelodysplastic/Myeloproliferative Syndrome with Ringsideroblasts and Thrombocytosis
Sign Up to like & getrecommendations! Published in 2019 at "Blood"
DOI: 10.1182/blood-2019-129077
Abstract: Background:In 2016 WHO recognized the provisional entity refractory anemia with ring sideroblasts and thrombocytosisas a distinct entity and renamed it myelodysplastic/myeloproliferative neoplasm with ring sideroblasts and thrombocytosis (MDS/MPN-RS-T). The disease presents hallmarks of both myelodysplastic… read more here.
Keywords: pegylated interferon; thrombocytosis; treatment; myelodysplastic myeloproliferative ... See more keywords
Pegylated interferon-α2b for local control of Langerhans cell sarcoma
Sign Up to like & getrecommendations! Published in 2018 at "European Journal of Dermatology"
DOI: 10.1684/ejd.2018.3411
Abstract: 835 cation as a CD8+ T-cell “lymphoproliferative disorder” is debated [7]. In contrast to PCAETCL, which requires aggressive polychemotherapy due to an ominous prognosis [2, 8], FUMHD is treated with systemic steroids, methotrexate [9], and/or… read more here.
Keywords: langerhans cell; pegylated interferon; cell sarcoma; control langerhans ... See more keywords
Comparison of pegylated interferon monotherapy and de novo pegylated interferon plus tenofovir combination therapy in patients with chronic hepatitis B
Sign Up to like & getrecommendations! Published in 2019 at "Infection and Drug Resistance"
DOI: 10.2147/idr.s195144
Abstract: Background and aim: We aimed to evaluate the effectiveness of pegylated interferon (Peg-IFN) monotherapy (IFN group) and combination therapy with tenofovir (TDF) and Peg-IFN (IFN+TDF group) in chronic hepatitis B (CHB) patients. Patients and methods:… read more here.
Keywords: response; pegylated interferon; treatment; ifn tdf ... See more keywords